Mark Robertson-Tessi

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Cancer research

Nature communications

Nature biotechnology

Physical biology

University of Arizona (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Arizona Sep 01 2005 - Jul 01 2010

United States

PHD :: Applied Mathematics

Publications

Maximilian A R Strobl, Alexandra L Martin, Jeffrey West, Jill A Gallaher, Mark Robertson-Tessi, Robert A Gatenby, Robert M Wenham, Philip K Maini, Mehdi Damaghi, Alexander A R A Anderson
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling. bioRxiv : the preprint server for biology (2023)
Chandler D Gatenbee, Ann-Marie C Baker, Sandhya Prabhakaran, Ottilie Swinyard, Robbert J C Slebos, Gunjan Mandal, Eoghan Mulholland, Noemi Andor, Andriy Marusyk, Simon Leedham, José R Conejo-Garcia, Christine H Chung, Mark Robertson-Tessi, Trevor A Graham, Alexander A R A Anderson
Virtual alignment of pathology image series for multi-gigapixel whole slide images. Nature communications 14 (1) (2023)
Jill A Gallaher, Maximilian A R Strobl, Jeffrey West, Robert A Gatenby, Jingsong Zhang, Mark Robertson-Tessi, Alexander A R A Anderson
Inter- and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics. Cancer research (2023)
Maximilian A R Strobl, Jill A Gallaher, Jeffrey West, Mark Robertson-Tessi, Philip K Maini, Alexander A R A Anderson
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition. Communications medicine 2 (2022)
Jasmine Foo, David Basanta, Russell C Rockne, Carly Strelez, Curran Shah, Kimya Ghaffarian, Shannon M Mumenthaler, Kelly Mitchell, Justin D Lathia, David E Frankhouser, Sergio Branciamore, Ya-Huei Kuo, Guido Marcucci, Robert Vander Velde, Andriy Marusyk, Sui Huang, Kishore Hari, Mohit Kumar Jolly, Haralampos Hatzikirou, Kamrine E Poels, Mary E Spilker, Blerta Shtylla, Mark Robertson-Tessi, Alexander A R A Anderson
Roadmap on plasticity and epigenetics in cancer. Physical biology 19 (3) (2022)
Calum Gabbutt, Ryan O Schenck, Daniel J Weisenberger, Christopher Kimberley, Alison Berner, Jacob Househam, Eszter Lakatos, Mark Robertson-Tessi, Isabel Martin, Roshani Patel, Susan K Clark, Andrew Latchford, Christopher P Barnes, Simon J Leedham, Alexander A R A Anderson, Trevor A Graham, Darryl Shibata
Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues. Nature biotechnology 40 (5) (2022)
Chandler D Gatenbee, Ann-Marie C Baker, Ryan O Schenck, Maximilian A R Strobl, Jeffrey West, Margarida P Neves, Sara Yakub Hasan, Eszter Lakatos, Pierre Martinez, William C H Cross, Marnix Jansen, Manuel Rodriguez, Christopher J Whelan, Andrea Sottoriva, Simon Leedham, Mark Robertson-Tessi, Trevor A Graham, Alexander A R A Anderson
Immunosuppressive niche engineering at the onset of human colorectal cancer. Nature communications 13 (1) (2022)
Jeffrey West, Ryan O Schenck, Chandler D Gatenbee, Mark Robertson-Tessi, Alexander A R A Anderson
Normal tissue architecture determines the evolutionary course of cancer. Nature communications 12 (1) (2021)
Tyler Cassidy, Daniel Nichol, Mark Robertson-Tessi, Morgan Craig, Alexander A R A Anderson
The role of memory in non-genetic inheritance and its impact on cancer treatment resistance. PLoS computational biology 17 (8) (2021)
Eszter Lakatos, Marc J Williams, Ryan O Schenck, William C H Cross, Jacob Househam, Luis Zapata, Benjamin Werner, Chandler Gatenbee, Mark Robertson-Tessi, Christopher P Barnes, Alexander A R A Anderson, Andrea Sottoriva, Trevor A Graham
Evolutionary dynamics of neoantigens in growing tumors. Nature genetics 52 (10) (2020)
Maximilian A R Strobl, Jeffrey West, Yannick Viossat, Mehdi Damaghi, Mark Robertson-Tessi, Joel S Brown, Robert A Gatenby, Philip K Maini, Alexander A R A Anderson
Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy. Cancer research 81 (4) (2020)
Derek S Park, Kimberly A Luddy, Mark Robertson-Tessi, Cliona O'Farrelly, Robert A Gatenby, Alexander A R A Anderson
Searching for Goldilocks: How Evolution and Ecology Can Help Uncover More Effective Patient-Specific Chemotherapies. Cancer research 80 (23) (2020)
Derek S Park, Mark Robertson-Tessi, Kimberly A Luddy, Philip K Maini, Michael B Bonsall, Robert A Gatenby, Alexander A R A Anderson
The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right. Cancer research 79 (20) (2019)

Mark Robertson-Tessi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mark Robertson-Tessi